Neurological
c. 1st–2nd century CE, Charaka Samhita, ancient Indian Ayurvedic tradition (Kampavata); also referenced in Egyptian papyri c. 1700 BCE
Parkinsonism, as a recognized medical concept, took shape gradually across centuries of fragmented observation before James Parkinson's 1817 essay brought it into formal medical discourse. Ancient healers had noticed trembling and rigidity in aging patients but lacked the conceptual framework to unify these observations into a single condition. The nineteenth and twentieth centuries transformed scattered clinical notes into a coherent neurological entity with identifiable pathological underpinnings.
Historical Narrative
The earliest written references to trembling disorders resembling what later generations would call Parkinsonism appeared in ancient Indian Ayurvedic texts, particularly the Charaka Samhita, composed roughly between the first and second centuries CE, which described a condition called Kampavata — a term rooted in words for trembling and wind-based bodily imbalance. Ancient Egyptian papyri, including fragments of the Edwin Smith Papyrus dating to around 1700 BCE, contained passing observations of elderly individuals who moved with stiffness and shaking, though no unified disease concept was attached to these descriptions. Greek and Roman physicians, including Galen in the second century CE, distinguished between different types of involuntary movement, separating tremor at rest from tremor during motion, a clinical distinction that would prove significant centuries later.
Throughout the medieval period, European understanding of trembling disorders remained embedded within humoral theory. Physicians attributed persistent shaking in older patients to an excess of cold and dry qualities within the nervous system, believed to reflect an imbalance of the melancholic humor. Religious interpretation also played a role, with some trembling conditions associated with spiritual affliction or divine punishment in popular culture, while monastic healers attempted herbal remedies thought to warm and moisten the humors.
The decisive turning point in the Western medical tradition came in 1817, when London apothecary and surgeon James Parkinson published his monograph An Essay on the Shaking Palsy. Drawing on observations of six individuals — some encountered on the street rather than as formal patients — Parkinson described a constellation of features including involuntary tremulous motion, diminished muscular power, and a propulsive gait, all while the senses and intellect remained largely unaffected. Parkinson himself relied on visual observation alone; he performed no autopsies and had no knowledge of the brain structures involved.
It was the French neurologist Jean-Martin Charcot who, decades later at the Salpêtrière hospital in Paris, refined and expanded Parkinson's observations substantially. Charcot disagreed with the term shaking palsy, noting that weakness was not a consistent feature, and he proposed renaming the condition la maladie de Parkinson in honor of the original describer. Charcot also distinguished the condition from other trembling disorders and experimented with hyoscine and other belladonna alkaloids derived from plants in the nightshade family, which became the dominant pharmacological approach for decades. He additionally introduced vibration therapy using specially constructed chairs, believing mechanical stimulation might counteract the nervous system's dysregulation.
In the late nineteenth and early twentieth centuries, neuropathologists began examining the brains of deceased patients, and by 1919, the Russian neurologist Konstantin Tretiakoff identified consistent degeneration within a midbrain structure he named the substantia nigra, establishing the first clear anatomical correlate of the disease. The 1920s epidemic of encephalitis lethargica, which left many survivors with Parkinsonian symptoms, further deepened researchers' interest in the condition's mechanisms and drew attention to the possibility of infectious or toxic origins. By mid-century, the biochemical revolution in neuroscience was well underway, and histochemical techniques in the 1950s and 1960s began revealing the role of specific chemical messengers in the affected brain regions, closing the long arc from ancient humoral speculation to cellular pathology.
Key Historical Figures
Historical narrative only — this page describes how Parkinsonism was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.